Last reviewed · How we verify
Community-acquired bacterial pneumonia
Approved treatments
- Ceftaroline Fosamil · Abbvie
Ceftaroline works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins. - Various · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Community-acquired bacterial pneumonia patent landscape — cliff calendar, originator estates, attackable patents
- Community-acquired bacterial pneumonia treatment landscape brief
- Community-acquired bacterial pneumonia treatment updates RSS
Frequently asked questions about Community-acquired bacterial pneumonia
What drugs treat Community-acquired bacterial pneumonia?
Tracked treatments include Ceftaroline Fosamil, Various.
What is the treatment for Community-acquired bacterial pneumonia?
Standard treatment for Community-acquired bacterial pneumonia includes Ceftaroline Fosamil, Various. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Community-acquired bacterial pneumonia patent cliff · Community-acquired bacterial pneumonia CI report
- Treatment: Ceftaroline Fosamil · Abbvie
- Treatment: Various · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing